Ntrk Gene Fusion-positive Solid Tumors
📧 Sign up to get email alerts when something new happens for Ntrk Gene Fusion-positive Solid Tumors.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2023-11-03FDA Approved: VITRAKVI — Supplemental Application (Loxo Oncology, Inc.)
FDA supplemental approval expands VITRAKVI's label to include treatment of NTRK gene fusion-positive solid tumors.